623144-14-9

Basic information

• Product Name: methyl 2-[(2,6-dichlorobenzoyl)amino]-3-(4-nitrophenyl)propanoate
• Synonyms: methyl 2-[(2,6-dichlorobenzoyl)amino]-3-(4-nitrophenyl)propanoate
• CAS NO: 623144-14-9
• Molecular Weight: 397.215
• Mol File: 623144-14-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 2-[(2,6-dichlorobenzoyl)amino]-3-(4-nitrophenyl)propanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-[(2,6-dichlorobenzoyl)amino]-3-(4-nitrophenyl)propanoate(623144-14-9)
• EPA Substance Registry System: methyl 2-[(2,6-dichlorobenzoyl)amino]-3-(4-nitrophenyl)propanoate(623144-14-9)

Safety Data

• Hazardous Substances Data: 623144-14-9(Hazardous Substances Data)

Upstream product

• 85317-52-8 methyl 2-amino-3-(4-nitrophenyl)propionate 
• 4659-45-4 2,6-Dichlorobenzoyl chloride 

Downstream Products

• 623144-15-0 methyl 3-(4-aminophenyl)-2-[(2,6-dichlorobenzoyl)amino]propanoate 

Relevant articles and documents

2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS

The present invention concerns 2,6-quinolinyl and 2,6-naphthyl derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals for the treatment of VLA-4 dependent inflammatory diseases such as for example asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, psoriasis, urticaria, pruritus, eczema, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and atherosclerosis. Formula (I): wherein X is N or CH.